911制品厂麻花

911制品厂麻花 | 听

Skip to Content on Nemours.org
# #

    Meet Our Team

    Learn more about our physician researchers, clinicians and scientists.

    Find a Researcher

    Partner With Us

    Join forces with our world-class research teams. Whether in academia, industry, or health care, let鈥檚 advance children鈥檚 health together.

    Learn How
    Partnerships

    Study With Us

    Our research fellows directly impact the work we do. See our education opportunities and join us.

    Apply Now

    Join Our Team

    Shape the future of pediatric medicine through groundbreaking research. Explore our research opportunities.

    View Positions
    Find a Researcher

    Anne E. Kazak, PhD

    Director, Nemours Center for Healthcare Delivery Sciences

    911制品厂麻花's Hospital, Delaware 1600 Rockland Road Wilmington, DE 19803

    Biography

    Anne E. Kazak, Ph.D., ABPP is the Enterprise Director of the Nemours Center for Healthcare Delivery Science and is based at 911制品厂麻花's Hospital in Wilmington, DE (NCH-D). She is Professor, Department of Pediatrics, Thomas Jefferson University, Philadelphia, PA and Professor, Department of Pediatrics, University of Pennsylvania. She also serves as an Adjunct Professor at the University of Delaware in the Dept of Psychological and Brain Sciences and in the College of Health Professions. Dr. Kazak is the Co-Director of the Center for Pediatric Traumatic Stress, part of the National Child Traumatic Stress Network. She is also Multiple Principal Investigator for the REACH (Research Expanding Access to Child Health) COBRE at NCH-D. She also serves as Nemours site MPI for PEDSNet. She is a licensed Psychologist and a Diplomat of the American Board of Professional Psychology. She is the Chief Editorial Advisor at the American Psychological Association (APA) and served as Editor-in-Chief of the Journal of Pediatric Psychology, Journal of Family Psychology, Health Psychology and American Psychologist. Dr. Kazak is an internationally recognized expert in pediatric health, known as a thought leader and accomplished investigator in the application of a social ecological approach to children's health to expand service delivery and improve overall outcomes. Dr. Kazak's research has shaped a systems-oriented competence-based understanding of the distress of children and their family members over the course of pediatric illness and treatment. She has had consistent federal (National Cancer Institute, National Institute of General Medical Sciences, Substance Abuse and Mental Health Services Administration, Bureau of Maternal and Child Health) and foundation (American Cancer Society, St Baldrick's Foundation, Alex's Lemonade Stand Foundation, CURESearch, Toy Foundation, Caplan Foundation, B+ Foundation) support for her research programs. She received the 2009 Cummings American Psychological Foundation PSYCHE Award for her work integrating psychology into healthcare systems. Dr. Kazak has extensive mentoring experience, including a Senior Mentoring Award from the NCI, and has mentored many national and international early career investigators. She received the 2019 Seema S. Sonnad Mentor of the Year Award from IDEA Delaware. In 2020 she was awarded a Compassionate Champion from the State of Delaware for her work on trauma informed care. Dr. Kazak has 300+ peer reviewed papers and chapters and three books.

    Internship

    • Psychology - Yale University School of Medicine, 1982

    Education

    • PhD - University of Virginia, 1983

    • Coping And Adaptation
    • Families
    • Pediatric
    • Psychology
    • Traumatic Stress

    • Benchmarks for Psychosocial Staffing in Pediatric Oncology: Implementing the Standards Together鈥擡ngaging Parents and Providers in Psychosocial Care (iSTEPPP) Study; Pediatric Blood & Cancer; (2025).

    • Family Psychosocial Risk, Neighborhood Opportunity, and Language in Pediatric Cancer; Pediatric Blood & Cancer; (2025).

    • Siblings of young children with congenital heart disease: parent perspectives from a crowdsourcing study; Journal of Pediatric Psychology; (2025).

    • Delivering Care Consistent With the Psychosocial Standards鈥擯rovider Report: Implementing the Standards Together鈥擡ngaging Parents and Providers in Psychosocial Care (iSTEPPP) Study; Pediatric Blood & Cancer; (2025).

    • mHealth App to Promote Healthy Lifestyles for Diverse Families Living in Rural Areas: Usability Study; JMIR Formative Research; (2025).

    • Partnership With Patient Advocacy Organizations Improves Research Recruitment; Pediatric Blood & Cancer; (2025).

    • Social Support Related to Menses in Gender Diverse Adolescents: A Qualitative Study; Journal of Pediatric and Adolescent Gynecology; (2025).

    • Topical review: family psychosocial risk screening and social determinants of health assessment; Journal of Pediatric Psychology; (2025).

    • Pediatric psychosocial preventative health model: Achieving equitable psychosocial care for children and families.; Families, Systems, & Health; (2024).

    • The Psychosocial Impact of the COVID-19 Pandemic on Families of Youth of Color: A Prospective Cohort Study; Journal of Pediatric Psychology; (2024).

    • Adaptation and pilot implementation of the Psychosocial Assessment Tool for Autism Spectrum Disorders (PAT-ASD); Journal of Autism and Developmental Disorders; (2023).

    • Acceptability and Feasibility of eSCCIP: Results From a Pilot Study of the Electronic Surviving Cancer Competently Intervention Program; Journal of Pediatric Psychology; (2023).

    • Validation of the Psychosocial Assessment Tool Sibling Module Follow-Up Version; Journal of Pediatric Psychology; (2023).

    • The Electronic Surviving Cancer Competently Intervention Program鈥攁 Psychosocial Digital Health Intervention for English- and Spanish-Speaking Parents of Children With Cancer: Protocol for Randomized Controlled Trial; JMIR Research Protocols; (2023).

    • Effects on Pediatric Cancer Survivors: The FAMily-Oriented Support (FAMOS) Randomized Controlled Trial; Journal of Pediatric Psychology; (2023).

    • The Electronic Surviving Cancer Competently Intervention Program鈥攁 Psychosocial Digital Health Intervention for English- and Spanish-Speaking Parents of Children With Cancer: Protocol for Randomized Controlled Trial (Preprint); Unknown Source; (2023).

    • Multicenter Analysis of Cardiometabolic-related Diagnoses in Transgender and Gender-Diverse Youth: A PEDSnet Study; The Journal of Clinical Endocrinology & Metabolism; (2022).

    • Validation of the COVID-19 Exposure and Family Impact Scales; Journal of Pediatric Psychology; (2022).

    • Initial Validation of a New Psychosocial Screener for Siblings of Youth with Cancer The Psychosocial Assessment Tool (PAT) Sibling Modules; Psycho-Oncology; (2022).

    • Advancing health equity in pediatric cancer through implementation of universal family psychosocial risk screening; Psycho-Oncology; (2022).

    • Validating the Factor Structure of the Psychosocial Assessment Tool Using Internet-Based Data; Journal of Pediatric Psychology; (2022).

    • Caregiver Religious Coping and Posttraumatic Responses in Pediatric Hematopoietic Stem Cell Transplant; Journal of Pediatric Psychology; (2021).

    • Editor's vale dictum: American Psychologist 2016鈥2021.; American Psychologist; (2021).

    • Longitudinal predictors of caregiver resilience outcomes at the end of childhood cancer treatment; Psycho-Oncology; (2021).

    • COVID-19 Exposure and Family Impact Scales: Factor Structure and Initial Psychometrics; Journal of Pediatric Psychology; (2021).

    • Home鈥恇ased cognitive behavioural therapy for families of young children with cancer (FAMOS): A nationwide randomised controlled trial; Pediatric Blood & Cancer; (2021).

    • Topical Review: Crowdsourcing as a Novel Approach to Qualitative Research; Journal of Pediatric Psychology; (2021).

    • Implementation of family psychosocial risk assessment in pediatric cancer with the Psychosocial Assessment Tool (PAT): study protocol for a cluster-randomized comparative effectiveness trial; Implementation Science; (2020).

    • Implementation of family psychosocial risk assessment in pediatric cancer with the Psychosocial Assessment Tool (PAT): Study protocol for a cluster randomized comparative effectiveness trial; Unknown Source; (2020).

    • Stability and change in family psychosocial risk over 6 months in pediatric cancer and its association with medical and psychosocial healthcare utilization; Pediatric Blood & Cancer; (2020).

    • Friendships in Pediatric Brain Tumor Survivors and Non-Central Nervous System Tumor Survivors; Journal of Pediatric Psychology; (2020).

    • Psychosocial Screening in Sickle Cell Disease: Validation of the Psychosocial Assessment Tool; Journal of Pediatric Psychology; (2020).

    • Strategies for Successful Recruitment and Retention of Parents in Pediatric Psychosocial eHealth Interventions: A Qualitative Study in Pediatric Oncology; Journal of Pediatric Psychology; (2020).

    • Psychology is an essential science: American Psychologist highlights the role of psychology in understanding and addressing COVID-19.; American Psychologist; (2020).

    • The impact of pediatric hematopoietic stem cell transplant timing and psychosocial factors on family and caregiver adjustment; Pediatric Blood & Cancer; (2020).

    • Tools to guide the identification and implementation of care consistent with the psychosocial Standards of care; Pediatric Blood & Cancer; (2020).

    • A psychosocial clinical care pathway for pediatric hematopoietic stem cell transplantation; Pediatric Blood & Cancer; (2019).

    • Historical Analysis: Editors' Reflections on 50 Years of the Journal of Pediatric Psychology; Journal of Pediatric Psychology; (2019).

    • The multidisciplinary pediatric psycho鈥恛ncology workforce: A national report on supervision for staff and training opportunities; Psycho-Oncology; (2018).